Alvotech (ALVO) vs GeneDx Holdings Corp. (WGS)
A side-by-side comparison of Alvotech and GeneDx Holdings Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALVO
Alvotech
$6.14HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
WGS
GeneDx Holdings Corp.
$71.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ALVO vs WGS
growth of $100 · dividends reinvested · last 4yALVO -45.4% (-14.0%/yr)WGS +60.5% (+12.6%/yr)WGS compounded faster over this window
ALVO WGS
ALVO vs WGS: by the numbers
- •WGS is the larger company ($2.13B vs $2.08B market cap).
- •Both run net losses; WGS's is the smaller (-23.40% vs -36.51% net margin).
- •ALVO grew revenue faster over the past five years (69.03% vs 16.28% CAGR).
Metrics side by side
Valuation
| Metric | ALVO | WGS |
|---|---|---|
| P/S ratio | 4.22 | 4.69 |
| P/B ratio | N/A | 8.73 |
| EV / EBITDA | 41.97 | N/A |
Profitability
| Metric | ALVO | WGS |
|---|---|---|
| Gross margin | 60.45% | 68.20% |
| Operating margin | 9.62% | -2.76% |
| Net margin | -36.51% | -23.40% |
| ROE | N/A | -43.55% |
| ROIC | 3.61% | -14.69% |
Growth (annualized)
| Metric | ALVO | WGS |
|---|---|---|
| Revenue CAGR (5Y) | 69.03% | 16.28% |
| Total return CAGR (5Y) | N/A | -19.67% |
Frequently asked
- Which has grown faster, ALVO or WGS?
- Over the past five years, ALVO grew revenue faster — ALVO at a 69.03% CAGR versus WGS at 16.28%.
Go deeper
Dig into the metrics
Alvotech ROEGeneDx ROEAlvotech operating marginGeneDx operating marginAlvotech revenue growthGeneDx revenue growthAlvotech free cash flowGeneDx free cash flow
Alvotech & GeneDx appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.